About Tricida, Inc.

Website
Website
Employees
Employees
51-200 employees View all
Industry
Industry
pharmaceuticals
Location
Location
7000 Shoreline Court,South San Francisco,CA,US
Description
Information
Tricida, Inc., is a pharmaceutical company focused on the development and commercialization of its drug candidate, veverimer (also known as TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with chronic kidney disease (CKD). Metabolic acidosis is a chronic condition commonly caused by CKD that is believed to accelerate the progression of CKD, increase the risk of muscle wasting and cause the loss of bone density.Tricida was founded in August 2013 by a seasoned management team that has extensive experience in the development and commercialization of therapeutics, with substantial expertise in developing polymers for the treatment of kidney-related diseases.

Tricida, Inc. Alternatives

Industry
biotechnology
Industry
biotechnology
Industry
Pharmaceuticals

Frequently Asked Questions about Tricida, Inc.

What is Tricida, Inc. email format?

The widely used Tricida, Inc. email format is {f}{last} (e.g. [email protected]) with 100% adoption across the company.


What is Tricida, Inc. customer service number?

To contact Tricida, Inc. customer service number in your country click here to find.


Who is the CEO of Tricida, Inc.?

Gerrit Klaerner is the CEO of Tricida, Inc..


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more